Premium
RAPID IMPROVEMENT IN VISUAL FIELD DEFECTS FOLLOWING BROMOCRIPTINE TREATMENT OF PATIENTS WITH NON‐FUNCTIONING PITUITARY ADENOMAS
Author(s) -
D'EMDEN M. C.,
HARRISON L. C.
Publication year - 1986
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1986.tb03625.x
Subject(s) - bromocriptine , chromophobe cell , medicine , pituitary adenoma , visual field , pituitary gland , pituitary neoplasm , immunohistochemistry , adenoma , endocrinology , pathology , prolactin , ophthalmology , hormone , clear cell
SUMMARY The role of bromocriptine in the treatment of non‐functioning pituitary tumours is not yet defined. Patients with these tumours who present with visual field defects usually undergo immediate surgery. Three consecutive patients are reported: each had rapid improvement in their visual field defects following bromocriptine 7.5 mg/d before surgery. Histological and immunohistochemical examination confirmed that their tumours were non‐functioning chromophobe adenomas. Their responses indicate that bromocriptine may have a role in the management of some patients with non‐functioning pituitary tumours.